- Home
- MCRB vs FTLF Comparison
MCRB vs FTLF Comparison
Compare MCRB & FTLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCRB
- FTLF
- Stock Information
- Founded
- MCRB 2010
- FTLF 2005
- Country
- MCRB United States
- FTLF United States
- Employees
- MCRB N/A
- FTLF N/A
- Industry
- MCRB Biotechnology: Pharmaceutical Preparations
- FTLF Medicinal Chemicals and Botanical Products
- Sector
- MCRB Health Care
- FTLF Health Care
- Exchange
- MCRB Nasdaq
- FTLF Nasdaq
- Market Cap
- MCRB 125.7M
- FTLF 149.3M
- IPO Year
- MCRB 2015
- FTLF N/A
- Fundamental
- Price
- MCRB $19.44
- FTLF $17.00
- Analyst Decision
- MCRB Hold
- FTLF Strong Buy
- Analyst Count
- MCRB 4
- FTLF 2
- Target Price
- MCRB $73.67
- FTLF $23.00
- AVG Volume (30 Days)
- MCRB 126.4K
- FTLF 21.6K
- Earning Date
- MCRB 08-06-2025
- FTLF 08-14-2025
- Dividend Yield
- MCRB N/A
- FTLF N/A
- EPS Growth
- MCRB N/A
- FTLF N/A
- EPS
- MCRB 10.22
- FTLF 0.80
- Revenue
- MCRB N/A
- FTLF $63,053,000.00
- Revenue This Year
- MCRB N/A
- FTLF $4.72
- Revenue Next Year
- MCRB N/A
- FTLF $6.61
- P/E Ratio
- MCRB $1.98
- FTLF $21.24
- Revenue Growth
- MCRB N/A
- FTLF 3.91
- 52 Week Low
- MCRB $6.53
- FTLF $9.83
- 52 Week High
- MCRB $26.40
- FTLF $17.75
- Technical
- Relative Strength Index (RSI)
- MCRB 69.44
- FTLF 68.46
- Support Level
- MCRB $15.79
- FTLF $16.52
- Resistance Level
- MCRB $18.12
- FTLF $17.20
- Average True Range (ATR)
- MCRB 1.51
- FTLF 0.86
- MACD
- MCRB 0.28
- FTLF 0.16
- Stochastic Oscillator
- MCRB 97.69
- FTLF 94.37
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.
About FTLF FitLife Brands Inc.
FitLife Brands Inc is a provider of proprietary nutritional supplements for health-conscious consumers. The company markets and sells its products under NDS, PMD, Siren labs, Core active, Metis nutrition, Isatori, and Biogenetic laboratories brand names. Its product portfolio consists of sports nutrition, energy, sports drink products, meal replacement products, and weight loss products. The firm derives its revenue from product sales. Its product categories include Natural & Organic Foods, Functional Foods, Natural & Organic Personal Care and Household Products, and Supplements.